Please note: This review reflects information we gathered on the date it was researched and may now be out of date. Providers frequently change their pricing, plans, medications, and policies. Any ratings, reviews, and customer feedback are gathered from publicly available online sources and may have since changed or no longer be accurate. Always do your own research and confirm the latest details directly with the provider before making any decision.
Brightmeds TRT Review: Lose The Weight, Then Retest
Brightmeds sells telehealth testosterone replacement at $75 a week with labs included, and requires lab-confirmed low testosterone before prescribing — a real gate, stated twice, which is more than much of this industry manages. But the most important fact for a reader of this site is not on their website at all: obesity lowers testosterone, weight loss raises it back, and if you are losing weight on a GLP-1 you may be about to buy a lifelong treatment for a problem that is fixing itself.
If you take nothing else from this page
Excess body fat converts testosterone into oestradiol and suppresses the brain signalling that drives testosterone production. That makes obesity-associated low testosterone functional and often reversible — and substantial weight loss raises endogenous testosterone, with bigger losses producing bigger rises. So if you are on a GLP-1, losing weight, and have been told your testosterone is low, the sequence that protects you is: lose the weight, let it stabilise for a couple of months, then retest. Starting TRT first suppresses your own production, can affect your fertility, is difficult to reverse, and costs roughly $3,900 a year indefinitely.
Our Verdict
Brightmeds · brightmeds.com · $75/week with labs included
A real clinical gate, stated twice, with free labs behind it
Their safety text: TRT is only prescribed if deemed medically necessary after a licensed clinician's evaluation and lab testing confirm low testosterone, and it is not prescribed for performance enhancement or cosmetic purposes. The footer repeats it and adds that evaluation includes a physician consultation, health history review and lab testing, and that TRT is not prescribed for bodybuilding, performance enhancement or aesthetics. Including labs at no charge backs that up structurally — charging for the gate is how you get people to skip it.
An adverse-effects list that names the three that matter
Most TRT marketing mentions acne and mood. Brightmeds prints reduced sperm production, which can lead to infertility; worsening of sleep apnea; and elevated red blood cell count, which can raise your risk of high blood pressure, joint or muscle pain or trouble with eyesight. Those are the three consequences a man should weigh hardest, and naming them costs the company customers. They also list gynaecomastia, fluid retention, raised cholesterol and blood sugar changes, and separately disclose side effects for enclomiphene and anastrozole.
The funnel opens with “Age Reversal” and the policy forbids it
The first screen of the TRT sign-up asks What's Your Goal? and offers Peak Performance, Mental Sharpness, Libido Boost, Live Longer Stronger, Age Reversal, Endless Stamina and Confidence Boost. Inches below sits the notice that TRT is not prescribed for performance enhancement or cosmetic purposes. Age Reversal and Peak Performance are cosmetic and performance goals by any reading. The fair interpretation is that the selector is lead marketing and the clinical gate operates later — but the funnel is soliciting exactly the motivations the policy excludes.
$75 a week is $3,900 a year
Weekly pricing makes a subscription look like a coffee habit. Converted, $75 a week is about $325 a month and roughly $3,900 a year — and because TRT is typically a long-term commitment once the axis is suppressed, that is an annual cost with no natural end date. The landing page also shows $100, $166, $266 and $299 without a structure we could resolve from outside the funnel. Price it annually before you decide, not weekly.
They also offer the fertility-preserving option
Alongside testosterone, Brightmeds prescribes enclomiphene, which raises your own testosterone by acting on the feedback loop rather than replacing the hormone — and therefore does not suppress sperm production the way TRT does. For a man who wants children, that distinction is the whole decision, and having the option available is a genuine point in this service's favour. It is compounded and not FDA-approved, which the site discloses.
Our Top Recommended Provider: CoreAge Rx
After reviewing dozens of GLP-1 telehealth providers, CoreAge Rx is the one we recommend most. CoreAge Rx is one of our partners — read on for why we recommend them:
Flat-Rate Pricing
Same cost at every dose level — no price jumps as you titrate up.
Verified Pharmacies
US-licensed physicians and NABP-verified 503A compounding pharmacies you can trust.
Everything Included
Medication, supplies, free shipping, and ongoing clinical support — no hidden fees.
Active Community of Members
Ask questions, share progress, and get answers from other patients on the same journey — alongside ongoing clinical support from your care team.
$3,900
A year, at $75 a week
Free
Labs, which is the gate for this drug
2 months
Weight stable before retesting
12
States excluded from this offer
Why weight loss changes the testosterone question entirely
This is the section that matters, and it is the one no TRT provider has an incentive to write. Excess adipose tissue does two things to male hormones. It expresses aromatase, the enzyme that converts testosterone into oestradiol, so more fat means more of your testosterone being turned into oestrogen. And excess weight suppresses the hypothalamic-pituitary-gonadal axis — the signalling chain from brain to testes that tells them to produce testosterone in the first place. The result is a genuinely low reading arising from a genuinely reversible cause.
Clinicians call this functional hypogonadism, and it behaves differently from the permanent kind. Substantial weight loss raises endogenous testosterone, consistently, across both surgical and non-surgical weight loss, and the relationship is dose-dependent: larger losses produce larger increases. A man carrying significant excess weight who tests low, then loses fifteen or twenty per cent of his body weight on a GLP-1, is not the same patient he was at baseline. Retesting him is not a formality — it can change the diagnosis.
Now put that beside what starting TRT does. Taking testosterone from outside suppresses your own production through ordinary negative feedback: the brain sees enough circulating hormone and stops signalling, the testes reduce output and often shrink, and sperm production falls — which is why infertility appears on Brightmeds' own side-effect list. Recovery after stopping can be slow and is not guaranteed, especially after prolonged use. So TRT is generally a long-term commitment, at roughly $3,900 a year here, entered into on the basis of a test result that your weight loss may be in the middle of changing.
The asymmetry is what makes this easy. Waiting costs you a few more months of feeling below par. Not waiting costs you a suppressed axis, a possible effect on fertility, a treatment that is hard to come off, and a four-figure annual bill that may never have been necessary. If a clinician has told you your testosterone is low while you are actively losing weight, the reasonable request is: let us repeat this once my weight has been stable for a couple of months. Any good clinician will agree, and the standard way to diagnose this anyway is two separate early-morning fasting measurements rather than one.
Two further overlaps worth knowing. Sleep apnoea: TRT can worsen it, and obstructive sleep apnoea is common at higher body weights — while GLP-1 weight loss improves it, as the tirzepatide sleep apnoea trials showed. Starting a drug that aggravates apnoea while losing weight that relieves it is working against yourself. And on cardiovascular safety, the reassuring evidence is real: the large TRAVERSE trial reported in the New England Journal of Medicine in 2023 found that testosterone therapy did not increase major adverse cardiac events in middle-aged and older men with hypogonadism and cardiovascular risk factors. That is a genuine answer to a longstanding worry — it is not, however, a reason to take a hormone you may not need.
What we verified
1. The gate is real, and the funnel undercuts it
Start with the credit, because it is substantial and it distinguishes this from the same company's NAD+ offering. Brightmeds states, in two separate places, that TRT requires lab-confirmed low testosterone following a clinician evaluation, and that it is not prescribed for performance enhancement, bodybuilding, cosmetic or aesthetic purposes. The footer version adds that evaluation includes a physician consultation, a health history review and lab testing, and frames the whole thing as being in accordance with FDA guidelines. Then they include the labs at no extra charge, which is the difference between a policy and a performance — a service that charges separately for the blood test creates an incentive to prescribe without one.
Against that, the first thing a prospective patient actually sees. The sign-up flow opens with What's Your Goal? Find the TRT Benefit That Fits You, and the options are Peak Performance, Mental Sharpness, Libido Boost, Live Longer Stronger, Age Reversal, Endless Stamina, Confidence Boost, and I'm interested in all benefits of TRT. Three of those — Peak Performance, Age Reversal, Endless Stamina — are precisely the performance and cosmetic motivations the safety notice on the same page says will not be treated.
We want to be fair about the likely explanation: goal selectors are standard lead-capture devices, they shape the marketing rather than the prescribing, and the clinical assessment presumably happens after. If so, the gate still holds and men picking Age Reversal will be turned away when their labs come back normal. But it means the funnel is actively recruiting on grounds the company has committed not to act on, which is either a wasted consultation for the patient or a quiet invitation to hope the gate is softer than advertised. A company that has written the right policy should not be advertising against it.
2. The safety disclosure is better than the category norm
Their listed effects for testosterone therapy: acne and oily skin; nausea, vomiting or headaches; fluid retention with lower-leg swelling; mood changes including irritability; worsening of sleep apnoea; reduced sperm production, which can lead to infertility; gynaecomastia; changes in urination; elevated red blood cell count, with the consequences spelled out as raised blood pressure, joint or muscle pain and eyesight trouble; abnormal blood sugar spikes raising type 2 diabetes risk; higher cholesterol; and injection site reactions. They add that this is not exhaustive and that routine follow-ups matter for monitoring.
That is a thorough list, and crucially it does not soften the two items most likely to change a man's mind — infertility and sleep apnoea. It also correctly frames erythrocytosis as needing monitoring rather than as a footnote; a rising haematocrit is the most common significant problem on TRT and the reason regular bloods are not optional. Free labs and an explicit follow-up expectation are the right structural answer to that.
They separately disclose effects for enclomiphene and anastrozole, which tells you those are part of the toolkit. Enclomiphene is the notable one: because it works on the feedback loop rather than replacing the hormone, it raises your own testosterone without the same suppression of sperm production, which makes it the conventional consideration for men who want to preserve fertility. Offering it at all is a mark of a service thinking beyond the simplest prescription. It is compounded and not FDA-approved, and Brightmeds says so — their compounding language notes that the FDA does not review the safety or effectiveness of compounded hormone therapies and that providers may prescribe off-label when medically appropriate.
3. Pricing, states, and what to ask before you commit
The headline is $75 per week with free labs. Weekly framing is worth resisting on any open-ended treatment: $75 a week is about $325 a month and roughly $3,900 a year, and TRT does not have a natural stopping point once your own production is suppressed. The landing page also displays $100, $166, $266 and $299 without a structure we could resolve from outside the sign-up flow, so treat the weekly figure as an entry point and get the plan you would actually be on quoted in writing, annually, before agreeing.
Twelve states are excluded from this offer: Alabama, Alaska, Arkansas, Delaware, Hawaii, Louisiana, Massachusetts, Mississippi, Missouri, South Carolina, Wisconsin and Wyoming. Worth noting that this list is not identical to the one for the company's other subcutaneous products — the NAD+ offer excludes Rhode Island but not Arkansas — so check the specific product against your specific state rather than assuming one map covers the platform. There is also a stated money-back guarantee if a prescription is not approved, which means a consultation that ends in a no does not cost you.
Four questions to put to whoever assesses you, whether here or anywhere. How many testosterone measurements will you base this on, and will they be early-morning and fasting — because the conventional standard is two separate morning readings, not one. Given I am actively losing weight, should we repeat the test after my weight stabilises. What is the monitoring schedule for haematocrit and how often will you check it. And if fertility matters to me, why testosterone rather than enclomiphene. A service that answers all four crisply is one worth using; a service that is impatient with the second one is telling you something.
Two routes to a higher testosterone level
| Route | Cost | Effect on your own production | Fertility |
|---|---|---|---|
| Losing weight, then retesting | $0 extra — you are already doing it | Raises it — removes the suppression | Unaffected or improved |
| Enclomiphene | Not separately published | Stimulates it via the feedback loop | Preserved — but compounded, not FDA-approved |
| Testosterone replacement | ~$325/mo, ~$3,900/yr, open-ended | Suppresses it — hard to reverse | Reduced sperm production; possible infertility |
Costs from brightmeds.com, retrieved 12 August 2026; the $3,900 annual figure is our arithmetic from the published $75 per week. The physiology columns describe the recognised mechanisms of each route and are not a recommendation for any individual — which route is appropriate depends on your test results, your goals and your clinician's assessment. Enclomiphene pricing was not published outside the sign-up funnel.
In its favour
- Requires lab-confirmed low testosterone before prescribing, and says so in two separate places on the site.
- States explicitly that TRT is not prescribed for performance enhancement, bodybuilding, cosmetic or aesthetic purposes.
- Labs are included at no extra cost — which removes the financial incentive to skip the test that gates the treatment.
- Publishes a thorough adverse-effects list that names infertility, worsening sleep apnoea and elevated red blood cell count.
- States that routine follow-ups are important for monitoring during treatment.
- Also prescribes enclomiphene, the fertility-preserving alternative, rather than offering testosterone only.
- Discloses that some treatments are compounded, that the FDA does not review compounded hormone therapies, and that prescribing may be off-label.
- Money-back guarantee if a prescription is not approved, so a consultation ending in a no is free.
- Three delivery options offered — injections, capsules and creams.
Against it
- The sign-up funnel solicits Age Reversal, Peak Performance and Endless Stamina — the exact goals its own policy excludes.
- $75 per week framing understates an open-ended commitment of roughly $3,900 a year.
- Additional figures of $100, $166, $266 and $299 appear with no resolvable structure outside the funnel.
- Nothing on the site tells a man losing weight that weight loss itself raises testosterone and that he should retest.
- Compounded testosterone and enclomiphene are not FDA-approved, so effectiveness has not been reviewed.
- Twelve states excluded, on a list that differs from the same company's other injectables.
- No published detail on how many testosterone measurements are required or whether they must be morning and fasting.
- No published monitoring schedule for haematocrit, which is the effect most needing regular blood checks.
- Sits in the same product grid as NAD+, glutathione and sermorelin, which have far weaker evidence.
Our verdict: 3.4 out of 5
A properly gated TRT service advertising itself with the motivations it refuses to treat — and if you are losing weight, the right first move is a repeat blood test, not a prescription.
This is the best of the three Brightmeds products we have reviewed, and the reason is the gate. TRT is a category with a serious problem: a large market of men who want to feel better, a drug that does make some of them feel better, and a strong commercial incentive to prescribe it regardless of whether their testosterone is actually low. Brightmeds writes the correct policy against that incentive — lab-confirmed low testosterone, clinician evaluation, explicitly not for performance, bodybuilding or aesthetics — states it twice, and then includes the labs for free so the gate cannot be avoided on cost. Their side-effect list names infertility, worsening sleep apnoea and rising red cell count without softening any of them, and they offer enclomiphene for men who need to protect fertility. That is a service that has thought about this properly.
Then the funnel asks whether your goal is Age Reversal. Alongside Peak Performance and Endless Stamina, on the screen immediately above the notice saying performance and cosmetic use is not treated. The charitable reading is that it is marketing and the clinical assessment sorts it out afterwards, and that is probably true. But it recruits men on the basis of hopes the company has committed not to fulfil, which wastes their time at best and at worst signals that the gate might be softer than the policy says. Having written the right rule, they should not be advertising against it.
On price, resist the weekly number. Seventy-five dollars a week is roughly $325 a month and $3,900 a year, and unlike a gym membership this is a treatment that becomes difficult to stop, because taking testosterone suppresses your own production and the recovery afterwards is neither quick nor guaranteed. Anything with those properties deserves to be priced annually in your head before you agree to it, and the additional figures scattered on the landing page mean you should get the specific plan quoted in writing.
But the most important thing in this review is not about Brightmeds at all, and it is missing from their site entirely. Body fat converts testosterone into oestradiol and suppresses the brain signalling that drives production, which makes obesity-related low testosterone functional rather than permanent — and losing substantial weight raises it back, in proportion to how much you lose. If you are on a GLP-1 and mid-way through losing fifteen or twenty per cent of your body weight, your testosterone is a moving number. Testing it now and treating the result as a diagnosis risks buying a lifelong hormone for a problem that was resolving on its own.
Three-point-four. If your weight has been stable for months, two morning fasting tests confirm low testosterone, and you understand the fertility and monitoring implications, this is a reasonable service to use and one of the more honestly gated ones we have looked at. If you are still losing weight, ask to be retested once it settles — a delay of a couple of months against a treatment that suppresses your own production, may affect your fertility, is hard to reverse and costs $3,900 a year. And if children are in your plans, ask specifically why testosterone rather than enclomiphene before you accept the first prescription offered. We are paid $40 when you buy, and postponing is still the advice.
Frequently asked questions
What is Brightmeds TRT?
Testosterone replacement therapy delivered by telehealth, from the same platform that sells compounded GLP-1s, FDA-approved Zepbound, sermorelin, glutathione and NAD+ injections. The TRT offering includes subcutaneous injections plus capsule and cream options, and the page also discloses side effects for enclomiphene and anastrozole, so those are prescribed too. Headline pricing is $75 per week with labs included, and treatment is stated to require lab-confirmed low testosterone.
What does it really cost?
The page title reads $75 Per Week, Free Labs. Weekly pricing makes a number look small, so convert it: $75 a week is about $325 a month and roughly $3,900 a year. The TRT landing page separately shows figures of $100, $166, $266 and $299, consistent with a ladder of plan options we could not fully resolve from outside the sign-up funnel. Free labs is genuinely valuable, because blood testing is the gate for this treatment and charging for it separately would create a reason to skip it.
Why should I wait before starting TRT if I'm losing weight?
Because the weight loss may fix the problem. Obesity is one of the most common causes of low testosterone in men, and the mechanism is well understood: fat tissue expresses aromatase, which converts testosterone into oestradiol, and excess weight also suppresses the hormonal signalling from the brain that tells the testes to produce testosterone. This form of low testosterone is functional rather than permanent. Substantial weight loss reliably raises endogenous testosterone, and the more weight lost, the larger the rise. A man with obesity and a low reading who then loses fifteen or twenty per cent of his body weight can look quite different on a repeat test.
So what should I actually do?
If you are early in GLP-1 treatment and have been told your testosterone is low, ask to be retested once your weight has been stable for a couple of months rather than starting hormone therapy now. That is a delay of months, not years, and the downside of waiting is some more months of feeling tired. The downside of not waiting is a treatment that suppresses your own production, may cost around $3,900 a year indefinitely, and can affect your fertility. The asymmetry is not close.
What are the real risks of TRT?
Brightmeds lists them unusually fully, and the three that matter most are all on their list. Reduced sperm production, which can lead to infertility — exogenous testosterone suppresses the signalling that drives sperm production, and recovery after stopping is not guaranteed. Worsening of sleep apnoea, which matters a great deal in this population. And elevated red blood cell count, the most common significant effect, which needs ongoing blood monitoring. They also name gynaecomastia, fluid retention, mood changes, acne, raised cholesterol, blood sugar changes and urinary changes.
Is TRT a lifelong commitment?
Usually, once you have started. Taking testosterone from outside suppresses your body's own production through normal negative feedback, so stopping means a period with neither source while the axis recovers — and recovery can be slow or incomplete, particularly after long use. That is the reason to establish first whether your low reading is permanent or a consequence of your weight. Starting is easy and reversing is not, which is precisely backwards from how the decision usually feels.
What if I want children?
Then TRT is probably the wrong drug and you should say so at the consultation. Testosterone therapy reduces sperm production and is not a fertility treatment. To Brightmeds' credit they also prescribe enclomiphene, which raises your own testosterone by acting on the feedback loop rather than replacing the hormone, and therefore does not suppress fertility in the same way — it is the standard consideration for men who want to preserve it. Note that enclomiphene is compounded and not FDA-approved, which the site does disclose.
How good is their clinical gate?
On paper, good, and they state it twice. Their safety text says TRT is only prescribed if deemed medically necessary after a licensed clinician's evaluation and lab testing confirm low testosterone, and that it is not prescribed for performance enhancement or cosmetic purposes. The footer repeats that treatment is only available to men with medically confirmed low testosterone, that evaluation includes a physician consultation, health history review and lab testing, and that it is not prescribed for bodybuilding, performance enhancement or aesthetics. Including free labs backs that up structurally rather than just rhetorically.
Then what is the criticism?
The funnel contradicts the policy. The first screen of the TRT sign-up asks What's Your Goal? Find the TRT Benefit That Fits You, and offers Peak Performance, Mental Sharpness, Libido Boost, Live Longer Stronger, Age Reversal, Endless Stamina and Confidence Boost. Age Reversal, Peak Performance and Endless Stamina are performance and cosmetic goals — the exact motivations the safety notice a few inches below says will not be treated. The charitable reading is that the selector is marketing and the clinical gate operates afterwards. Either way, men are being invited in on grounds that are supposed to disqualify them.
Where is it unavailable?
This offer excludes twelve states: Alabama, Alaska, Arkansas, Delaware, Hawaii, Louisiana, Massachusetts, Mississippi, Missouri, South Carolina, Wisconsin and Wyoming. Note that the exclusion list differs slightly between this offer and the same company's other injectables, so check your state against the specific product rather than assuming one list covers everything.
If you are still losing weight, retest before you buy
Ask for two morning fasting testosterone measurements, taken after your weight has been stable for a couple of months. Ask what the haematocrit monitoring schedule is. If you want children, ask why testosterone rather than enclomiphene. And price it annually — $75 a week is about $3,900 a year. We earn $40 either way, and a repeat blood test pays us nothing.
Visit Brightmeds TRT (affiliate link)Pricing, safety information and state restrictions verified 12 August 2026 and subject to change.
Compare Other GLP-1 Providers
See how other telehealth providers stack up.
Form Health
Comprehensive ProgramMultidisciplinary obesity medicine program with physicians, dietitians, and behavioral coaching
Read Review →JumpstartMD
Comprehensive ProgramMedically supervised program with obesity medicine physicians, dietitians, and in-person options
Read Review →CoreAge Rx
#1 RecommendedFlat-rate pricing for compounded semaglutide and tirzepatide with NABP-verified pharmacies
Read Review →GoodRx Care
Trusted BrandTelehealth platform from GoodRx with transparent pricing and established trust
Read Review →Boston Medical Group
Top RatedEstablished telehealth provider with physician oversight and transparent pricing
Read Review →Mochi Health
Obesity Medicine SpecialistsBoard-certified obesity medicine specialists with both brand-name and compounded GLP-1 options
Read Review →Medical disclaimer
This article is informational and is not medical advice. Testosterone replacement therapy is a prescription treatment with significant effects: it suppresses endogenous testosterone production, reduces sperm production and can cause infertility, can worsen obstructive sleep apnoea, and commonly raises red blood cell count, which requires ongoing blood monitoring. It should only be started after proper assessment by a clinician including confirmatory laboratory testing, and it is not appropriate for performance, bodybuilding or cosmetic purposes. Do not start, stop or adjust testosterone or any hormone therapy on the basis of a product review, and do not obtain it without a genuine clinical assessment. Compounded testosterone, enclomiphene and anastrozole are not FDA-approved and their effectiveness has not been reviewed by the FDA. Men with prostate cancer, breast cancer, untreated severe sleep apnoea, uncontrolled heart failure, or who are trying to conceive require specific specialist advice. Discuss all medications you take, including GLP-1 receptor agonists, with the clinician assessing you. If you are losing weight, whether to test or retest and when is a clinical decision for your doctor, not a decision this article can make for you.
Sources · date reviewed: 12 August 2026
- brightmeds.com/testosterone-replacement-therapy/start — retrieved 12 August 2026. Source for the page title Choose Your TRT Goal: $75 Per Week, Free Labs; for the goal selector What's Your Goal? Find the TRT Benefit That Fits You with options Peak Performance, Mental Sharpness, Libido Boost, Live Longer Stronger, Age Reversal, Endless Stamina, Confidence Boost and I'm interested in all benefits of TRT; for the safety statement that TRT is only prescribed if deemed medically necessary after a licensed clinician's evaluation and lab testing confirm low testosterone and that it is not prescribed for performance enhancement or cosmetic purposes; for the compounding disclosure that some treatments may be compounded and are not FDA-approved, that the FDA does not review the safety or effectiveness of compounded hormone therapies, and that providers may prescribe off-label when medically appropriate; for the full adverse-effects lists for testosterone, enclomiphene and anastrozole reproduced in this review, including reduced sperm production which can lead to infertility, worsening of sleep apnea, and elevated red blood cell count with its stated consequences; for the statement that routine follow-ups with your doctor are important for monitoring; for the description of subcutaneous injection treatment; and for the footer text stating that TRT treatment is only available to men with medically confirmed low testosterone levels in accordance with the FDA's guidelines, that evaluation includes a physician consultation, health history review and lab testing, and that TRT is not prescribed for bodybuilding, performance enhancement or aesthetic purposes.
- start.brightmeds.com/testosterone-replacement-therapy/ and brightmeds.com/products — retrieved 12 August 2026. Source for the additional price figures of $100, $166, $266 and $299 whose structure we could not resolve outside the sign-up funnel; for the product-page description of Testosterone Replacement TRT for Men as offering 3 Customized Treatment Options (Injections, Capsules, Creams) with claimed benefits Boosts Energy & Libido and Builds Lean Muscle & Strength; and for the 100% money back guarantee if a prescription is not approved. brightmeds.com/robots.txt permits crawling in full.
- Katalys offer listing #1371, retrieved 12 August 2026 — flat $40.00 commission, Health & Beauty and Health & Wellness verticals, United States targeting, conversion event Purchase, NET 60 terms, sub-network Brightmeds. Source for the restricted state list of Alabama, Alaska, Arkansas, Delaware, Hawaii, Louisiana, Massachusetts, Mississippi, Missouri, South Carolina, Wisconsin and Wyoming, and for the statement that doctors can only prescribe if BMI is over 30.
- Adipose tissue expresses aromatase, which converts testosterone to oestradiol, and excess adiposity suppresses the hypothalamic-pituitary-gonadal axis — the recognised mechanisms of obesity-associated functional hypogonadism. Substantial weight loss increases endogenous testosterone in men, with the magnitude of increase related to the magnitude of weight loss, observed following both surgical and non-surgical weight reduction. This is the basis for our recommendation to retest after weight stabilises.
- Exogenous testosterone suppresses gonadotrophin secretion through negative feedback, reducing endogenous testosterone production and spermatogenesis; recovery after discontinuation may be prolonged and is not guaranteed, particularly after extended use. Enclomiphene acts as a selective oestrogen receptor modulator raising endogenous testosterone via the feedback axis and does not suppress spermatogenesis in the same manner. Erythrocytosis is the most frequent clinically significant adverse effect of testosterone therapy and requires haematocrit monitoring. Testosterone therapy can exacerbate obstructive sleep apnoea. Diagnosis of hypogonadism conventionally requires at least two separate early-morning fasting measurements of total testosterone.
- The TRAVERSE trial, reported in the New England Journal of Medicine in 2023, found that testosterone replacement therapy did not result in a greater incidence of major adverse cardiac events than placebo in middle-aged and older men with hypogonadism and pre-existing or high risk of cardiovascular disease.
- Obstructive sleep apnoea is strongly associated with obesity, and tirzepatide reduced the apnoea-hypopnoea index in adults with obesity and moderate-to-severe obstructive sleep apnoea in the SURMOUNT-OSA trials reported in the New England Journal of Medicine in 2024 — the basis for our observation that TRT and GLP-1 weight loss act in opposite directions on apnoea.
Limitations, stated plainly. We did not complete a consultation, undergo testing, obtain a prescription or use any product, and we have no information about the compounding pharmacies used, the quality of any preparation, or how rigorously the stated lab requirement is applied in practice — we can report the published policy, not its enforcement. We could not resolve the full pricing ladder, because only the $75 weekly headline and four unlabelled figures are visible outside the sign-up funnel, which we did not enter; the $3,900 annual figure is our own arithmetic from the published weekly rate. We could not establish how many testosterone measurements are required, whether they must be morning and fasting, or what haematocrit monitoring interval is used, because none of that is published. State restrictions come from the affiliate listing rather than the company's eligibility checker. We could not reach independent review platforms. We did not contact Brightmeds before publishing.
Affiliate disclosure
GLP1Drugs.org is paid a flat $40 for each purchase made through the links on this page. We have rated Brightmeds TRT 3.4 out of 5 and built the review around advice that a large share of readers should not buy yet — that men losing weight on a GLP-1 should have their testosterone retested after their weight stabilises, because obesity suppresses testosterone and weight loss raises it back. We converted the $75 weekly headline into its $3,900 annual reality, flagged that the sign-up funnel solicits the performance and anti-ageing goals the company's own policy refuses to treat, and pointed men who want children towards enclomiphene rather than testosterone. No company reviewed here sees or approves our copy before publication.